Clinical trial

Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE

NCT05649046

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-01-23

PhaseNA

Study timeline

Study start (actual)2023-01-23Date precision: day

Registry last updated2024-03-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Smoking-related Pathologyunresolved

Atheromaunresolved

Chronic Bronchitisunresolved

Non-progressive Cancer > 5 Yearsunresolved

Lung Cancerunresolved

Interventions

thoracic scan Low doseDEVICE

BLOOD SAMPLEBIOLOGICAL

FECES SAMPLEBIOLOGICAL

Sponsors & collaborators

Assistance Publique Hopitaux De Marseillelead sponsor

Mapped research locations

MarseilleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05649046 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.